05-17 Macro Group Pharmaceutical Q1 consol profit egp 33.3 million RE
02-19 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-19 Macro Group Pharmaceutical FY consol profit EGP 115.7 mln RE
11-18 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-13 Macro Group Pharmaceutical nine-month consol loss EGP 66.1 million RE
25-10-12 Macro Group Pharmaceutical shareholders approve authorized capital increase to EGP 3 billion RE
25-08-21 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-08-21 Macro Group Pharmaceutical posts Q2 consol profit EGP 46.5 mln RE
25-08-21 Macro Group Pharmaceutical board approves renewal of EGP 100 mln short-term financing from KFH RE
25-07-22 Macro Group Pharmaceutical board proposes capital increase RE
25-06-10 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-10 MACRO Group Pharmaceutical's 328.6 Million Shares Block Traded For EGP 631 Million - EGX RE
25-02-26 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2024 CI
24-11-12 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-09-04 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-07-30 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-04-16 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023 CI
23-11-15 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
23-05-16 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
23-03-28 Rimco EGT Investment acquired 3.2% stake in Macro Group Pharmaceutical for EGP 61.5 million. CI
23-03-02 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2022 CI
22-11-04 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
22-05-29 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
22-03-07 Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2021 CI
No results match your criteria
  1. Stock Market
  2. Stocks
  3. MCRO Stock
  4. News Macro Group Pharmaceuticals (Macro Capital) S.A.E
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!